In studying how the brain cells, neurotransmitters and neuropeptides interact and communicate with the rest of the body, researchers are working to develop improved treatments for people incapacitated by psychiatric and neurological disorders. The term used to summarise all of the biological sciences involved in understanding the brain, and how drugs can be made to affect it, is neuropsychopharmacology.
The detailed way fundamental processes of the brain have been discovered in the last years is showing great promise of yielding methods to treat and prevent disorders of the brain.
The role of neuropsychopharmacology
Neuropsychopharmacology, which developed out of previously isolated fields, bridges the gap between basic neurosciences and the treatment of neuropsychiatric diseases. It engages a broad range of professionals from psychiatrists and neurologists to researchers in brain imaging, genetics, molecular biology, chronobiology, neuroimmunology or neurochemistry. As an interdisciplinary science related to neurosciences and psychopharmacology (how drugs affect the mind), it includes research of neuropathology, pharmacodynamics (drug action), psychiatry and neurology. It also has an impact on emerging cross-disciplinary disciplines such as neuroethics, neuropedagogics, neurophilosophy or neurotheology.
A central assumption in neuropsychopharmacology is that all states of mind as well as diseases involving mental or cognitive dysfunction have a neurochemical basis. Thus, the understanding of neurons in the brain is central to understanding the mind, and essential for the understanding and treatment of mental disorders. On a practical level, the goal of neuropsychopharmacology is to develop specifi
|Contact: Sonja Mak|
European College of Neuropsychopharmacology